CD4 and neoplasm: Taken together, these studies suggest that physiologic sources of HGFL support mammary tumorigenesis by promoting tumor cell proliferation, limiting tumor cell death, recruiting M2 (Arginase-1+) macrophages, and suppressing CD4+ and CD8a+ T cell recruitment.